US equities |
MU $903.70 ▲+0.00% META $630.56 ▲+0.00% SKHY $142.62 ▲+0.00% TSLA $391.62 ▲+0.00% NVDA $216.00 ▲+0.00% SPCX $146.90 ▲+0.00% SNDK $1,255.58 ▲+0.00% INTC $90.47 ▲+0.00%
FinancialContent

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

41.49 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Enliven Therapeutics, Inc. - Common Stock

News headline image
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
Issued on behalf of Oncolytics Biotech Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence